OTR Tablet 10 mg Fasted-state Bioequivalence Study
Status:
Completed
Trial end date:
2017-09-07
Target enrollment:
Participant gender:
Summary
This is an open-label, single Dose, randomised, cross-over study to confirm the
bioequivalence (BE) of OTR tablet 10 mg and OXYCONTIN tablet 10 mg in a fasted state in
Chinese subjects with chronic pain